For 25 years, the University Area Community Development Corporation’s (CDC) Prodigy Cultural Arts Program has enriched the ...
today announced the presentation of a trial-in-progress poster on the Company’s first-in-human clinical trial evaluating FOG-001, the first and only direct inhibitor of β-catenin TCF4 ...